Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WHY WOULD GOV. TAKE THEIR PASSPORTS
WHAT'S NEXT....JAIL AND "0" SHAREVALUE UNTIL CLASS ACTION WON.
In case you don't know what I am talking about. The company fudged the first trial and that is why it is so different than the second. See, to get their treatment to work, they made the people on the first trial have a colonostomy so the drug would be able to work, even though they knew if this were approved based on that, nobody would be able to get a butt cleaned out, every time they take the drug daily. CROOKS, AND They planned the trial update. Put the sell order to happen before the announcement, and hope nobody would find out. Well THE ATTORNEYS DID AND ARE DOING SOMETHING ABOUT IT TO GET EVERY BIT OF MONEY BACK. PUT A HOLD ON ALL MONIES. PUT MGMT. IN JAIL AND ANY OTHERS PARTICIPATING IN INSIDER TRADING.
What’s Next For Seres Therapeutics?
http://marketexclusive.com/whats-next-seres-therapeutics-inc-nasdaqmcrb/9901/?icd1
I love a parade. Like I said yesterday. HERE COMES THE JUDGE! SUB DOLLAR STOCK WITHIN A DAY OR SO THEN OUT OF BUSINESS...SIGN ON THE DOOR. WE SCAMMED THE FDA SEC AND SHAREHOLDERS. INSIDERS ARE LAUGHING ON BOTH SIDES OF THE TRADE. UNREAL LIES ON THE STUDY, LIES ABOUT TIMING OF SELLING. NOW, WE KNOW THEY KNEW HOW IT WOULD TURN OUT BECAUSE THEY NEVER CLEANED OUT THE BUTTS IN THE 2ND TRIAL. LOL BUTTHEADS
Sell on Rally Play Near Term
Great balance sheet. 100+ million, multi-year related party license agreement payment in Q1. But not going to be profitable for years to come. The company's Microbiome Therapeutics might also have been over-hyped.
Near term short. Could be short-on-rally swing trade candidate over the next few years too. Be opportunistic.
Willing to change view as we go.
Nice entry.. Mine $9.67
I'm in at 8.11 should hit 16 to 20 this week imo
Panic sells Friday= Watch/Buy Monday... MCRB
Based on what?
$1 before bell, and I am being generous.
UNBELIEVE ABLE...CROOKS: So, they rigged the 1st trial! unreal, but I figured. THEN, they sell 3 million shares and buy a few hundred. UNREAL.
AND, you keep saying am I short! No, I got beat when I woke up and my stock went from 50 to 8 bucks. Yeah, my attorney and accountant think I AM Shorted!
Seres Therapeutics (NASDAQ:MCRB) Postulation
I awoke today to something I absolutely did not expect - the report of Seres Therapeutics down over 70% on bad "surprise" data. It didn't make sense.
How can you have Phase I data that showed 96.7% (29 of 30) of the patients achieving clinical resolution by week 8 and Phase II data that showed no difference between placebo:
Based on 8-week data, CDI recurrence occurred in 44% of subjects (26 of 59) who received SER-109, compared to 53% of subjects (16 of 30) who received placebo.
Statistically, this just screams impossible. Something must be different in their methodology, otherwise this is a statistical anomaly.
So I dug. The Phase I trial design is not on clinicaltrials.gov, but you can find it here. There are some interesting things in the methods, but let me highlight these points:
http://seekingalpha.com/article/3993931-seres-therapeutics-matter-details
Back to $35, easy. Monumental naked short squeeze impending.
VC
No doubt. 81% institution owned...none of them are selling at these levels..see you at $15+
RAGS TO RICHES TO RAGS TO JAIL AND FINED FOR FRUAD. ATTORNEYS WILL BE ALL OVER THIS. THIS IS A SUB PENNY STOCK RIGHT NOW!
INSIDER PRE PLANNED SALES WORKED OUT JUST PERFECT FOR EVERY EVERY EVERY POS MANAGEMENT IN THE COMPANY. HERE'S HOW IT'S DONE. FDA GAVE THEM A PRESET DATE BECAUSE OF THIS BEING A TRIAL AND WE KNOW WHEN IT WILL END. IF IT TURNS OUT GOOD AND THEY ARE SELLING...SO WHAT, THEY MAKE 50 BUCKS A SHARE FOR CRAP. IF THE TRIAL TURNS OUT BAD....THEN AGAIN THEY MAKE A FORTUNE AND THEN SOME AT THE EXPENSE OF SHAREHOLDERS THAT THEY GAVE NO SUCH INSIDE INFORMATION TO. CROOKS...YOU BET YOU AZ
370 million cash....yeah, in your dreams..and or in the ceo and family accounts. 370 mil cash with a company with no nadda products,. income, grants, FUTURE! LOL
Yeah, being short really scares me with a company even the owners sold out on. Lol
Lol, especially since it'll be at $15 this week
MCRB As of 6/30/16 they had $370 MILLION in cash on hand, which is almost close to what their current market cap is!!! If I was short,I don`t think I could SLEEP?? (monday,monday,just wait)!
You shorted this @8 didn't you??? SUCKS I'm sorry
CAREFUL Pauline: this stock is going to "0", and I think the class action will get shareholders money back after these crooks go to jail!
$44 That's what the INSIDERS STOLE WED AND THUR. AND THE MONTH BEFORE MILLIONS MORE. They have the total online. ATTORNEY'S AND SEC WILL BE ALL OVER THIS ONE. Crooks...I have never seen such bold and obvious moves, and since these sells were planned, that means the management knew when the decision would be coming down, and can't say they were blind to what the drug test failure was over the trial. CROOKS SHOULD GO TO JAIL UNDER THE SARBANE OXLEY ACT AND FINED AND THROW AWAY THE KEY. NEVER BEFORE...EVER HAVE I SEEN SUCH BLATENT CROOKERY!
Your holding Short? Brave Trader!!? I`m holding long,if it goes down, I have a little room to get out!!
OH, SORRY...WITH THEIR MILLIONS...THEY WILL LET THIS COMPANY GO BANKRUPT. 5 OTHER COMPANIES HAVE THE SAME PRODUCT WAITING APPROVAL AND MORE TESTING. BANK ON IT.
"0" that's what this company is worth now. oh, what did insider's do the last two months, and they say they just found out about the trial failure. filings...form 4 sell sell sell sell sell sell sell....they sold all their shares for a fortune compared to what it went to today. ATTORNEYS WILL BE IN FULL FORCE THIS WEEKEND. AND THIS THIS THIS COMPANY DESERVES IT. I WILL JOIN ANY CLASS ACTION ON THESE CROOKS. THIS COMPANY ISN'T WORTH A DIME. NOBODY GIVING GRANTS, NADDA...NOTHING. SOLD SOLD SOLD SOLD SOLD...YEP THE INSIDERS GOT TO SELL THEIR SHARES FOR OVER 30 BUCKS A SHARE. THEN THEY SHORTED THE STOCK FOR MORE PROFIT. CROOKS...SARBANE OXLEY ACT: PUT THEM IN JAIL!
* $MCRB Video Chart 07-29-16 * *
Link to Video - click here to watch the technical chart video
July 29, 2016- "Currently, the analyst consensus on Seres Therapeutics is Strong Buy and the average price target is $46.50, representing a 445.8% upside." -According to The Fly, cowen & Co. analyst Ritu Baral reiterated a Buy rating on Seres Therapeutics (NASDAQ: MCRB) today. The company’s shares opened today at $8.52.
Ritu Baral, 4 star ranked analyst.
According to TipRanks.com, Baral is a 4-star analyst with an average return of 4.6% and a 44.6% success rate. Baral covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Protalix Biotherapeutics, and Intra-Cellular Therapies.
http://www.analystratings.com/2016/07/29/seres-therapeutics-receives-a-buy-from-cowen-co-2/448028/
Bought in big @8.11 this morning
300 million cash and no debt. $25 minimum
July 29th, 2016-- Research analysts at HC Wainwright started coverage on shares of Seres Therapeutics Inc. (NASDAQ:MCRB) in a research report issued to clients and investors on Friday. The brokerage set a “buy” rating and a $50.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 39.78% from the company’s previous close. -- http://www.com-unik.info/hc-wainwright-begins-coverage-on-seres-therapeutics-inc-mcrb/
OR WE COULD GO TO ZERO WITH NO INCOME....FLIP THAT COIN
LOOKS LIKE THEY CONTINUE STUDY. Works in the over 65 group, and they need it. Tweek it for trial 1 results and what may have changed in trial 2. Could bounce big. buying more.
https://www.tradingview.com/chart/MCRB/iXMHGtWZ-MCRB-Trading-at-CASH/
Called it in the morning. This is trading at CASH. Sold my positions, Will watch for a future setup.
It seems the insiders have been selling and filing everyday for months. is this correct? something stinks
Followers
|
30
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
356
|
Created
|
06/25/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |